论文部分内容阅读
[目的]探讨蠲痛饮对子宫内膜异位症患者的血清抗子宫内膜抗体作用。[方法]将60例患者随机分为观察组与对照组两组,每组各30例,观察组服用蠲痛饮,对照组服用孕三烯酮。观察并分析两组治疗前后血清抗子宫内膜抗体(EmAb)的OD值。[结果]蠲痛饮治疗子宫内膜异位患者血清抗子宫内膜抗体(EmAb)的P/N值降低至1.57±0.35,与孕三烯酮对照组疗效相似(P=0.884﹥0.05),但较对照组更加显著。蠲痛饮治疗观察组氨基转移酶升高2例,痤疮1例,总不良反应率为10.0%,显著低于孕三烯酮对照组的33.3%(P﹤0.05)。[结论]蠲痛饮可有效调降子宫内膜异位症患者抗子宫内膜抗体(EmAb)的P/N值,且不良反应发生率低。
[Objective] To explore the effect of Tongtongyin on serum anti-endometrial antibody in patients with endometriosis. [Method] Sixty patients were randomly divided into observation group and control group, with 30 cases in each group. The observation group took 蠲 Tong Yin and the control group took gestrinone. The OD value of serum anti-endometrial antibody (EmAb) before and after treatment was observed and analyzed. [Results] The P / N value of serum anti-endometrial antibody (EmAb) in patients with endometriosis was significantly decreased to 1.57 ± 0.35 (P = 0.884> 0.05), and the effect was similar to that of gesthenone control group But more significant than the control group.蠲 pain treatment group 2 cases of elevated aminotransferase, acne in 1 case, the total adverse reaction rate was 10.0%, significantly lower than gestrinone control group 33.3% (P <0.05). [Conclusion] Yi Tong Yin can effectively reduce the P / N value of anti-endometrial antibody (EmAb) in patients with endometriosis, and the incidence of adverse reactions is low.